Sonova Holding AG (ETR:PHBN)
| Market Cap | 18.86B +51.0% |
| Revenue (ttm) | 3.93B +4.7% |
| Net Income | 520.76M -7.0% |
| EPS | 8.99 -6.6% |
| Shares Out | n/a |
| PE Ratio | 35.22 |
| Forward PE | 23.97 |
| Dividend | 5.08 (1.60%) |
| Ex-Dividend Date | Jun 19, 2026 |
| Volume | n/a |
| Open | 317.70 |
| Previous Close | 318.80 |
| Day's Range | 316.70 - 317.70 |
| 52-Week Range | 207.00 - 318.80 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 12, 2026 |
About Sonova Holding AG
Sonova Holding AG manufactures and sells hearing care solutions for children and adults in Switzerland, the United States, rest of the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through Hearing Instruments, Cochlear Implants, and Lifestyle-Aligned segments. The Hearing Instruments segment engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitr... [Read more]
Financial Performance
In fiscal year 2026, Sonova Holding AG's revenue was 3.61 billion, a decrease of -0.19% compared to the previous year's 3.61 billion. Earnings were 430.60 million, a decrease of -20.33%.
Financial numbers in CHF Financial StatementsNews
Barclays double upgrades Sonova to Overweight, prefers in hearing aid space
As previously reported, Barclays upgraded Sonova (SONVY) to Overweight from Underweight with a price target of CHF 330, up from CHF 220. An improving hearing aid market benefits both Sonova…
Sonova upgraded to Overweight from Underweight at Barclays
Barclays upgraded Sonova (SONVY) to Overweight from Underweight.
Sonova Holding AG Transcript: H1 26/27
H1 sales rose 7.5% in local currencies and core EBIT grew 22.9%, with hearing instruments and wholesale leading. FY sales and core EBIT guidance increased, alongside stepped-up strategic investment; cochlear implant recovery depends partly on Integro’s U.S. approval timing.
Sonova Holding AG Slides: H1 2027
Sonova Holding AG has posted slides in relation to its H1 2027 quarterly earnings report, which was published on November 12, 2026.
Sonova Holding AG Earnings release: H1 2027
Sonova Holding AG released its H1 2027 earnings on November 12, 2026, summarizing the period's financial results.
Sonova Holding AG Quarterly report: H1 2027
Sonova Holding AG has published its H1 2027 quarterly earnings report on November 12, 2026.
SONOVA HOLDING AG Profit Rises In Six Months
(RTTNews) - SONOVA HOLDING AG (SONVF.PK) announced earnings for its six months that Increased, from last year
Switzerland's Sonova raises full-year forecasts on market-share gains, product launches
Swiss hearing aid maker Sonova on Thursday raised its sales and profit forecasts for its 2027 financial year, citing market share gains and solid uptake of new products.
Sonova upgraded to Hold from Underperform at Jefferies
Jefferies analyst Martinien Rula upgraded Sonova (SONVY) to Hold from Underperform with a price target of CHF 275, up from CHF 170. While market conditions have improved and largely reduced…
Sonova downgraded to Sector Perform from Outperform at RBC Capital
RBC Capital downgraded Sonova (SONVY) to Sector Perform from Outperform with a price target of CHF 283, up from CHF 250. The firm cites valuation for the downgrade following the…
Sonova downgraded to Neutral from Buy at UBS
UBS downgraded Sonova (SONVY) to Neutral from Buy with a price target of CHF 293, up from CHF 273. While the firm says it remains “constructive” on Sonova’s fundamentals, it…
Sonova price target raised to CHF 250 from CHF 205 at Citi
Citi raised the firm’s price target on Sonova (SONVY) to CHF 250 from CHF 205 and keeps a Sell rating on the shares.
Sonova upgraded to Buy from Neutral at Goldman Sachs
Goldman Sachs analyst Richard Felton upgraded Sonova (SONVY) to Buy from Neutral with a price target of CHF 315, up from CHF 230. The firm sees above-market growth for Sonova…
Sonova price target raised to CHF 245 from CHF 205 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Sonova (SONVY) to CHF 245 from CHF 205 and keeps an Equal Weight rating on the shares.
Sonova unveils new AI-powered hearing-aid platform to support growth targets
Sonova launched its third hearing-aid platform utilising real-time AI on Monday, its latest effort to strengthen its position in a market that relies on rapid technology upgrades to shorten replacem...
Sonova price target raised to CHF 205 from CHF 169 at Citi
Citi raised the firm’s price target on Sonova (SONVY) to CHF 205 from CHF 169 and keeps a Sell rating on the shares.
Sonova upgraded to Buy from Neutral at UBS
UBS upgraded Sonova (SONVY) to Buy from Neutral with a price target of CHF 242, up from CHF 206. The shares are trading at their near-largest discount to Demant in…
Sonova upgraded to Equal Weight from Underweight at Morgan Stanley
Morgan Stanley upgraded Sonova (SONVY) to Equal Weight from Underweight with a price target of CHF 205, up from CHF 172. The firm says signs of a growth inflection coupled…
Sonova price target raised to CHF 189 from CHF 163 at JPMorgan
JPMorgan analyst David Adlington raised the firm’s price target on Sonova (SONVY) to CHF 189 from CHF 163 and keeps a Neutral rating on the shares.
Sonova Holding AG Transcript: H2 25/26
Delivered strong sales and profit growth, driven by innovation and market share gains in hearing instruments and retail, while cochlear implants faced headwinds. Outlook for 2026-2027 is positive, with continued above-market growth and margin expansion expected.
Sonova Holding AG Earnings release: H2 2026
Sonova Holding AG released its H2 2026 earnings on May 18, 2026, summarizing the period's financial results.
Sonova Holding AG Annual report: H2 2026
Sonova Holding AG has published its H2 2026 annual report on May 18, 2026.
Sonova Holding AG Slides: H2 2026
Sonova Holding AG has posted slides in relation to its H2 2026 quarterly earnings report, which was published on May 18, 2026.
Sonova price target lowered to CHF 169 from CHF 210 at Citi
Citi lowered the firm’s price target on Sonova (SONVY) to CHF 169 from CHF 210 and keeps a Sell rating on the shares.
Sonova price target lowered to CHF 172 from CHF 184 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Sonova (SONVY) to CHF 172 from CHF 184 and keeps an Underweight rating on the shares.